Global Respiratory Drugs and Devices Market Research and Analysis, 2014-2020
Market Insight
Global Respiratory Drugs and Devices Market is expected to grow at a CAGR of 8% for the forecasted period of 2015-2020. Respiratory drugs market has 65% market share compared to 35% market share of respiratory devices market. The market is driven by growing prevalence of respiratory diseases and disorders. There is been constant growth in the number of cases asthma and COPD. Asthma and COPD account for approximately 60% of the respiratory drugs and devices market. Ageing population and major lifestyle changes have led to rise in respiratory diseases. Habits such as overeating, smoking, lack of exercise and other major lifestyle changes are causing respiratory diseases. Cases of respiratory disorder are also on a rise in new born.
Respiratory drugs and devices companies are concentrating on developing new products. Companies are expanding their product portfolios and increasing their R&D budget. Major respiratory devices include therapeutic devices such as masks, ventilators, humidifiers, positive airway pressure devices and other devices. Other respiratory devices include diagnostic and monitoring devices and consumables and accessories meters. Respiratory drugs segmented on the basis of route of administration and drugs class.
North America is the leading market with over XX% share. The market is expected to grow at a stable CAGR. North American market is driven by high sales of branded drugs and high number of patient diagnosed and treated for respiratory diseases. North American marker is followed by Europe, Asia Pacific and Rest of the world. Asia Pacific market is expected to have highest CAGR amongst all regions for the forecasted period of 2015-2020. APAC market is driven by growing ageing population with respiratory disorders. Pollution and lifestyle changes are also driving the APAC market.
Global Respiratory Drugs and Devices Market is expected to grow at a CAGR of 8% for the forecasted period of 2015-2020. Respiratory drugs market has 65% market share compared to 35% market share of respiratory devices market. The market is driven by growing prevalence of respiratory diseases and disorders. There is been constant growth in the number of cases asthma and COPD. Asthma and COPD account for approximately 60% of the respiratory drugs and devices market. Ageing population and major lifestyle changes have led to rise in respiratory diseases. Habits such as overeating, smoking, lack of exercise and other major lifestyle changes are causing respiratory diseases. Cases of respiratory disorder are also on a rise in new born.
Respiratory drugs and devices companies are concentrating on developing new products. Companies are expanding their product portfolios and increasing their R&D budget. Major respiratory devices include therapeutic devices such as masks, ventilators, humidifiers, positive airway pressure devices and other devices. Other respiratory devices include diagnostic and monitoring devices and consumables and accessories meters. Respiratory drugs segmented on the basis of route of administration and drugs class.
North America is the leading market with over XX% share. The market is expected to grow at a stable CAGR. North American market is driven by high sales of branded drugs and high number of patient diagnosed and treated for respiratory diseases. North American marker is followed by Europe, Asia Pacific and Rest of the world. Asia Pacific market is expected to have highest CAGR amongst all regions for the forecasted period of 2015-2020. APAC market is driven by growing ageing population with respiratory disorders. Pollution and lifestyle changes are also driving the APAC market.
REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINATION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. TAX LAWS
2.6.1.1. UNITED STATES
2.6.1.2. EUROPEAN UNION
2.6.1.3. CHINA
2.6.1.4. INDIA
2.6.1.5. REST OF THE WORLD
2.6.2. DRUG AND DEVICE REGULATIONS
2.6.2.1. UNITED STATES
2.6.2.2. EUROPEAN UNION
2.6.2.3. CHINA
2.6.2.4. INDIA
2.6.2.5. REST OF THE WORLD
2.7. RESPIRATORY DISEASES
2.7.1. ASTHMA
2.7.2. COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)
2.7.3. CYSTIC FIBROSIS
2.7.4. CHRONIC BRONCHITIS
2.7.5. EMPHYSEMA
2.7.6. ALLERGIC RHINITIS
2.7.7. OTHER
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES SUCH AS ASTHMA
3.1.2. GROWING CASES OF RESPIRATORY DISEASES IN NEW BORN AND CHILDREN
3.1.3. AGEING POPULATION
3.1.4. CHANGING LIFESTYLE AND RISE IN OBESITY
3.1.5. SMOKING AND POLLUTION
3.1.6. INNOVATIONS AND DEVELOPMENT OF NEW PRODUCTS
3.2. RESTRAINT
3.2.1. REIMBURSEMENTS AND STRICT GOVERNMENT REGULATIONS IN EMERGING MARKETS
3.2.2. HIGH PRICE
3.2.3. LIMITED AWARENESS AND AVAILABILITY IN EMERGING MARKETS
3.3. OPPPORTUNITY
3.3.1. GROWING DEMAND FOR REMOTE MONITORING AND HOME CARE PRODUCTS
3.3.2. EMERGING MARKETS
PARENT MARKET ANALYSIS
MARKET SEGMENTATION
5.1. GLOBAL RESPIRATORY DRUGS AND DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1. GLOBAL RESPIRATORY DEVICES BY PRODUCT MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1. GLOBAL RESPIRATORY THERAPEUTIC DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.1. GLOBAL RESPIRATORY POSITIVE AIRWAY PRESSURE DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.1.1. GLOBAL RESPIRATORY CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.1.2. GLOBAL RESPIRATORY AUTOMATIC PAP (APAP) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.1.3. GLOBAL RESPIRATORY BI-LEVEL PAP (BPAP) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.2. GLOBAL RESPIRATORY MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.2.1. GLOBAL RESPIRATORY NASAL MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.2.2. GLOBAL RESPIRATORY FULL-FACE MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.2.3. GLOBAL RESPIRATORY NASAL PILLOW MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.2.4. GLOBAL RESPIRATORY ORAL MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.3. GLOBAL RESPIRATORY VENTILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.3.1. GLOBAL RESPIRATORY ADULT VENTILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.3.2. GLOBAL RESPIRATORY INFANT/NEONATAL VENTILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.4. GLOBAL RESPIRATORY NEBULIZERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.5. GLOBAL RESPIRATORY HUMIDIFIERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.5.1. GLOBAL RESPIRATORY HEATED HUMIDIFIERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.5.2. GLOBAL RESPIRATORY PASSOVER HUMIDIFIERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.6. GLOBAL RESPIRATORY OXYGEN CONCENTRATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.6.1. GLOBAL RESPIRATORY FIXED OXYGEN CONCENTRATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.6.2. GLOBAL RESPIRATORY PORTABLE OXYGEN CONCENTRATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.7. GLOBAL RESPIRATORY INHALERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.7.1. GLOBAL RESPIRATORY DRY POWDER INHALERS (DPIS) MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.7.2. GLOBAL RESPIRATORY METERED DOSE INHALERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.8. GLOBAL RESPIRATORY REUSABLE RESUSCITATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.8.1. GLOBAL RESPIRATORY ADULT RESUSCITATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.8.2. GLOBAL RESPIRATORY INFANT/NEONATAL RESUSCITATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.9. GLOBAL RESPIRATORY NITRIC OXIDE DELIVERY UNITS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.10. GLOBAL RESPIRATORY OXYGEN HOODS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2. GLOBAL RESPIRATORY DIAGNOSTIC AND MONITORING DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.1. GLOBAL RESPIRATORY PULSE OXIMETERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.1.1. GLOBAL RESPIRATORY PULSE OXIMETER SENSORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.1.2. GLOBAL RESPIRATORY PULSE OXIMETER EQUIPMENT MARKET RESEARCH AND ANALYSIS, 2014-2020 MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.2. GLOBAL RESPIRATORY CAPNOGRAPHS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.3. GLOBAL RESPIRATORY GAS ANALYZERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.4. GLOBAL RESPIRATORY SPIROMETERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.5. GLOBAL RESPIRATORY POLYSOMNOGRAPHY (PSG) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.6. GLOBAL RESPIRATORY PEAK FLOW METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.3. GLOBAL RESPIRATORY CONSUMABLES AND ACCESSORIES METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.3.1. GLOBAL RESPIRATORY DISPOSABLE MASKS METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.3.2. GLOBAL RESPIRATORY DISPOSABLE RESUSCITATORS METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.3.3. GLOBAL RESPIRATORY TRACHEOSTOMY TUBES METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.3.4. GLOBAL RESPIRATORY NASAL CANNULAS METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.3.5. GLOBAL RESPIRATORY OTHER CONSUMABLES AND ACCESSORIES METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2. GLOBAL RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.1. GLOBAL RESPIRATORY DRUGS BY ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.1.1. GLOBAL ORAL RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.1.2. GLOBAL INJECTABLE RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.1.3. GLOBAL INHALABLE RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2. GLOBAL RESPIRATORY DRUGS BY DRUG CLASS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.1. GLOBAL ANTICHOLINERGICS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.2. GLOBAL ANTIHISTAMINES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.3. GLOBAL BETA2 AGONISTS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.4. GLOBAL ANTIASTHMATIC COMBINATIONS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.5. GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.6. GLOBAL LEUKOTRIENE INHIBITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.7. GLOBAL MAST CELL STABILIZERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.8. GLOBAL PHOSPHODIESTERASE 4 (PDE4) INHIBITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.9. GLOBAL BRONCHODILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.10. GLOBAL DECONGESTANTS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.11. GLOBAL EXPECTORANTS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.12. GLOBAL OTHER RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2. GLOBAL RESPIRATORY DISEASES MARKET BY END USERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.1. GLOBAL RESPIRATORY DRUGS AND DEVICES MARKET BY HOSPITALS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.2. GLOBAL RESPIRATORY DISEASES MARKET BY HOME CARE MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.3. GLOBAL RESPIRATORY DISEASES MARKET BY OTHER END USERS MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPETETIVE LANDSCAPE
6.1. MARKET SHARE ANAYSIS
6.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.4. ROPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANY PROFILES
8.1. PHILIPS HEALTHCARE
8.1.1. INTRODUCTION
8.1.2. PHILIPS HEALTHCARE PRODUCT PORTFOLIO
8.1.3. PHILIPS HEALTHCARE RECENT ACTIVITIES
8.1.4. PHILIPS HEALTHCARE SWOT
8.2. NOVARTIS
8.2.1. INTRODUCTION
8.2.2. NOVARTIS PRODUCT PORTFOLIO
8.2.3. NOVARTIS RECENT ACTIVITIES
8.2.4. NOVARTIS SWOT
8.3. GLAXOSMITHKLINE
8.3.1. INTRODUCTION
8.3.2. GLAXOSMITHKLINE PRODUCT PORTFOLIO
8.3.3. GLAXOSMITHKLINE RECENT ACTIVITIES
8.3.4. GLAXOSMITHKLINE SWOT
8.4. ASTRAZENECA
8.4.1. INTRODUCTION
8.4.2. ASTRAZENECA PRODUCT PORTFOLIO
8.4.3. ASTRAZENECA RECENT ACTIVITIES
8.4.4. ASTRAZENECA SWOT
8.5. COVIDIEN PLC
8.5.1. INTRODUCTION
8.5.2. COVIDIEN PLC PRODUCT PORTFOLIO
8.5.3. COVIDIEN PLC RECENT ACTIVITIES
8.5.4. COVIDIEN PLC SWOT
8.6. ROCHE
8.6.1. INTRODUCTION
8.6.2. ROCHE PRODUCT PORTFOLIO
8.6.3. ROCHE RECENT ACTIVITIES
8.6.4. ROCHE SWOT
8.7. BAXTER INTERNATIONAL
8.7.1. INTRODUCTION
8.7.2. BAXTER PRODUCT PORTFOLIO
8.7.3. BAXTER RECENT ACTIVITIES
8.7.4. BAXTER SWOT
8.8. GE HEALTHCARE LIMITED
8.8.1. INTRODUCTION
8.8.2. GE HEALTHCARE PRODUCT PORTFOLIO
8.8.3. GE HEALTHCARE RECENT ACTIVITIES
8.8.4. GE HEALTHCARE SWOT
8.9. AIR LIQUIDE S.A.
8.9.1. INTRODUCTION
8.9.2. AIR LIQUIDE PRODUCT PORTFOLIO
8.9.3. AIR LIQUIDE RECENT ACTIVITIES
8.9.4. AIR LIQUIDE SWOT
8.10. OTSUKA PHARMACEUTICALS
8.10.1. INTRODUCTION
8.10.2. OTSUKA PRODUCT PORTFOLIO
8.10.3. OTSUKA RECENT ACTIVITIES
8.10.4. OTSUKA SWOT
8.11. PFIZER
8.11.1. INTRODUCTION
8.11.2. PFIZER PRODUCT PORTFOLIO
8.11.3. PFIZER RECENT ACTIVITIES
8.11.4. PFIZER SWOT
8.12. MERCK AND CO.
8.12.1. INTRODUCTION
8.12.2. MERCK PRODUCT PORTFOLIO
8.12.3. MERCK RECENT ACTIVITIES
8.12.4. MERKC SWOT
8.13. BOEHRINGER INGELHEIM
8.13.1. INTRODUCTION
8.13.2. BOEHRINGER INGELHEIM PRODUCT PORTFOLIO
8.13.3. BOEHRINGER INGELHEIM RECENT ACTIVITIES
8.13.4. BOEHRINGER INGELHEIM SWOT
8.14. TEVA PHARMACEUTICALS
8.14.1. INTRODUCTION
8.14.2. TEVA PRODUCT PORTFOLIO
8.14.3. TEVA RECENT ACTIVITIES
8.14.4. TEVA SWOT
8.15. COMPUMEDICS LIMITED
8.15.1. INTRODUCTION
8.15.2. COMPUMEDICS PRODUCT PORTFOLIO
8.15.3. COMPUMEDICS RECENT ACTIVITIES
8.15.4. COMPUMEDICS SWOT
8.16. FISHER AND PAYKEL HEALTHCARE CORP. LTD
8.16.1. INTRODUCTION
8.16.2. FISHER AND PAYKEL PRODUCT PORTFOLIO
8.16.3. FISHER AND PAYKEL RECENT ACTIVITIES
8.16.4. FISHER AND PAYKEL SWOT
8.17. CHART INDUSTRIES
8.17.1. INTRODUCTION
8.17.2. CHART PRODUCT PORTFOLIO
8.17.3. CHART RECENT ACTIVITIES
8.17.4. CHART SWOT
8.18. INVACARE CORPORATION
8.18.1. INTRODUCTION
8.18.2. INVACARE PRODUCT PORTFOLIO
8.18.3. INVACARE RECENT ACTIVITIES
8.18.4. INVACARE SWOT
8.19. DRAGER MEDICAL GMBH
8.19.1. INTRODUCTION
8.19.2. DRAGER PRODUCT PORTFOLIO
8.19.3. DRAGER RECENT ACTIVITIES
8.19.4. DRAGER SWOT
8.20. HAMILTON MEDICAL AG
8.20.1. INTRODUCTION
8.20.2. HAMILTON PRODUCT PORTFOLIO
8.20.3. HAMILTON RECENT ACTIVITIES
8.20.4. HAMILTON SWOT
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINATION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. TAX LAWS
2.6.1.1. UNITED STATES
2.6.1.2. EUROPEAN UNION
2.6.1.3. CHINA
2.6.1.4. INDIA
2.6.1.5. REST OF THE WORLD
2.6.2. DRUG AND DEVICE REGULATIONS
2.6.2.1. UNITED STATES
2.6.2.2. EUROPEAN UNION
2.6.2.3. CHINA
2.6.2.4. INDIA
2.6.2.5. REST OF THE WORLD
2.7. RESPIRATORY DISEASES
2.7.1. ASTHMA
2.7.2. COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)
2.7.3. CYSTIC FIBROSIS
2.7.4. CHRONIC BRONCHITIS
2.7.5. EMPHYSEMA
2.7.6. ALLERGIC RHINITIS
2.7.7. OTHER
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES SUCH AS ASTHMA
3.1.2. GROWING CASES OF RESPIRATORY DISEASES IN NEW BORN AND CHILDREN
3.1.3. AGEING POPULATION
3.1.4. CHANGING LIFESTYLE AND RISE IN OBESITY
3.1.5. SMOKING AND POLLUTION
3.1.6. INNOVATIONS AND DEVELOPMENT OF NEW PRODUCTS
3.2. RESTRAINT
3.2.1. REIMBURSEMENTS AND STRICT GOVERNMENT REGULATIONS IN EMERGING MARKETS
3.2.2. HIGH PRICE
3.2.3. LIMITED AWARENESS AND AVAILABILITY IN EMERGING MARKETS
3.3. OPPPORTUNITY
3.3.1. GROWING DEMAND FOR REMOTE MONITORING AND HOME CARE PRODUCTS
3.3.2. EMERGING MARKETS
PARENT MARKET ANALYSIS
MARKET SEGMENTATION
5.1. GLOBAL RESPIRATORY DRUGS AND DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1. GLOBAL RESPIRATORY DEVICES BY PRODUCT MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1. GLOBAL RESPIRATORY THERAPEUTIC DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.1. GLOBAL RESPIRATORY POSITIVE AIRWAY PRESSURE DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.1.1. GLOBAL RESPIRATORY CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.1.2. GLOBAL RESPIRATORY AUTOMATIC PAP (APAP) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.1.3. GLOBAL RESPIRATORY BI-LEVEL PAP (BPAP) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.2. GLOBAL RESPIRATORY MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.2.1. GLOBAL RESPIRATORY NASAL MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.2.2. GLOBAL RESPIRATORY FULL-FACE MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.2.3. GLOBAL RESPIRATORY NASAL PILLOW MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.2.4. GLOBAL RESPIRATORY ORAL MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.3. GLOBAL RESPIRATORY VENTILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.3.1. GLOBAL RESPIRATORY ADULT VENTILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.3.2. GLOBAL RESPIRATORY INFANT/NEONATAL VENTILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.4. GLOBAL RESPIRATORY NEBULIZERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.5. GLOBAL RESPIRATORY HUMIDIFIERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.5.1. GLOBAL RESPIRATORY HEATED HUMIDIFIERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.5.2. GLOBAL RESPIRATORY PASSOVER HUMIDIFIERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.6. GLOBAL RESPIRATORY OXYGEN CONCENTRATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.6.1. GLOBAL RESPIRATORY FIXED OXYGEN CONCENTRATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.6.2. GLOBAL RESPIRATORY PORTABLE OXYGEN CONCENTRATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.7. GLOBAL RESPIRATORY INHALERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.7.1. GLOBAL RESPIRATORY DRY POWDER INHALERS (DPIS) MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.7.2. GLOBAL RESPIRATORY METERED DOSE INHALERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.8. GLOBAL RESPIRATORY REUSABLE RESUSCITATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.8.1. GLOBAL RESPIRATORY ADULT RESUSCITATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.8.2. GLOBAL RESPIRATORY INFANT/NEONATAL RESUSCITATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.9. GLOBAL RESPIRATORY NITRIC OXIDE DELIVERY UNITS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.1.10. GLOBAL RESPIRATORY OXYGEN HOODS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2. GLOBAL RESPIRATORY DIAGNOSTIC AND MONITORING DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.1. GLOBAL RESPIRATORY PULSE OXIMETERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.1.1. GLOBAL RESPIRATORY PULSE OXIMETER SENSORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.1.2. GLOBAL RESPIRATORY PULSE OXIMETER EQUIPMENT MARKET RESEARCH AND ANALYSIS, 2014-2020 MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.2. GLOBAL RESPIRATORY CAPNOGRAPHS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.3. GLOBAL RESPIRATORY GAS ANALYZERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.4. GLOBAL RESPIRATORY SPIROMETERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.5. GLOBAL RESPIRATORY POLYSOMNOGRAPHY (PSG) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.2.6. GLOBAL RESPIRATORY PEAK FLOW METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.3. GLOBAL RESPIRATORY CONSUMABLES AND ACCESSORIES METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.3.1. GLOBAL RESPIRATORY DISPOSABLE MASKS METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.3.2. GLOBAL RESPIRATORY DISPOSABLE RESUSCITATORS METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.3.3. GLOBAL RESPIRATORY TRACHEOSTOMY TUBES METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.3.4. GLOBAL RESPIRATORY NASAL CANNULAS METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1.3.5. GLOBAL RESPIRATORY OTHER CONSUMABLES AND ACCESSORIES METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2. GLOBAL RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.1. GLOBAL RESPIRATORY DRUGS BY ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.1.1. GLOBAL ORAL RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.1.2. GLOBAL INJECTABLE RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.1.3. GLOBAL INHALABLE RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2. GLOBAL RESPIRATORY DRUGS BY DRUG CLASS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.1. GLOBAL ANTICHOLINERGICS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.2. GLOBAL ANTIHISTAMINES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.3. GLOBAL BETA2 AGONISTS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.4. GLOBAL ANTIASTHMATIC COMBINATIONS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.5. GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.6. GLOBAL LEUKOTRIENE INHIBITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.7. GLOBAL MAST CELL STABILIZERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.8. GLOBAL PHOSPHODIESTERASE 4 (PDE4) INHIBITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.9. GLOBAL BRONCHODILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.10. GLOBAL DECONGESTANTS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.11. GLOBAL EXPECTORANTS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2.2.12. GLOBAL OTHER RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2. GLOBAL RESPIRATORY DISEASES MARKET BY END USERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.1. GLOBAL RESPIRATORY DRUGS AND DEVICES MARKET BY HOSPITALS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.2. GLOBAL RESPIRATORY DISEASES MARKET BY HOME CARE MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.3. GLOBAL RESPIRATORY DISEASES MARKET BY OTHER END USERS MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPETETIVE LANDSCAPE
6.1. MARKET SHARE ANAYSIS
6.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.4. ROPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANY PROFILES
8.1. PHILIPS HEALTHCARE
8.1.1. INTRODUCTION
8.1.2. PHILIPS HEALTHCARE PRODUCT PORTFOLIO
8.1.3. PHILIPS HEALTHCARE RECENT ACTIVITIES
8.1.4. PHILIPS HEALTHCARE SWOT
8.2. NOVARTIS
8.2.1. INTRODUCTION
8.2.2. NOVARTIS PRODUCT PORTFOLIO
8.2.3. NOVARTIS RECENT ACTIVITIES
8.2.4. NOVARTIS SWOT
8.3. GLAXOSMITHKLINE
8.3.1. INTRODUCTION
8.3.2. GLAXOSMITHKLINE PRODUCT PORTFOLIO
8.3.3. GLAXOSMITHKLINE RECENT ACTIVITIES
8.3.4. GLAXOSMITHKLINE SWOT
8.4. ASTRAZENECA
8.4.1. INTRODUCTION
8.4.2. ASTRAZENECA PRODUCT PORTFOLIO
8.4.3. ASTRAZENECA RECENT ACTIVITIES
8.4.4. ASTRAZENECA SWOT
8.5. COVIDIEN PLC
8.5.1. INTRODUCTION
8.5.2. COVIDIEN PLC PRODUCT PORTFOLIO
8.5.3. COVIDIEN PLC RECENT ACTIVITIES
8.5.4. COVIDIEN PLC SWOT
8.6. ROCHE
8.6.1. INTRODUCTION
8.6.2. ROCHE PRODUCT PORTFOLIO
8.6.3. ROCHE RECENT ACTIVITIES
8.6.4. ROCHE SWOT
8.7. BAXTER INTERNATIONAL
8.7.1. INTRODUCTION
8.7.2. BAXTER PRODUCT PORTFOLIO
8.7.3. BAXTER RECENT ACTIVITIES
8.7.4. BAXTER SWOT
8.8. GE HEALTHCARE LIMITED
8.8.1. INTRODUCTION
8.8.2. GE HEALTHCARE PRODUCT PORTFOLIO
8.8.3. GE HEALTHCARE RECENT ACTIVITIES
8.8.4. GE HEALTHCARE SWOT
8.9. AIR LIQUIDE S.A.
8.9.1. INTRODUCTION
8.9.2. AIR LIQUIDE PRODUCT PORTFOLIO
8.9.3. AIR LIQUIDE RECENT ACTIVITIES
8.9.4. AIR LIQUIDE SWOT
8.10. OTSUKA PHARMACEUTICALS
8.10.1. INTRODUCTION
8.10.2. OTSUKA PRODUCT PORTFOLIO
8.10.3. OTSUKA RECENT ACTIVITIES
8.10.4. OTSUKA SWOT
8.11. PFIZER
8.11.1. INTRODUCTION
8.11.2. PFIZER PRODUCT PORTFOLIO
8.11.3. PFIZER RECENT ACTIVITIES
8.11.4. PFIZER SWOT
8.12. MERCK AND CO.
8.12.1. INTRODUCTION
8.12.2. MERCK PRODUCT PORTFOLIO
8.12.3. MERCK RECENT ACTIVITIES
8.12.4. MERKC SWOT
8.13. BOEHRINGER INGELHEIM
8.13.1. INTRODUCTION
8.13.2. BOEHRINGER INGELHEIM PRODUCT PORTFOLIO
8.13.3. BOEHRINGER INGELHEIM RECENT ACTIVITIES
8.13.4. BOEHRINGER INGELHEIM SWOT
8.14. TEVA PHARMACEUTICALS
8.14.1. INTRODUCTION
8.14.2. TEVA PRODUCT PORTFOLIO
8.14.3. TEVA RECENT ACTIVITIES
8.14.4. TEVA SWOT
8.15. COMPUMEDICS LIMITED
8.15.1. INTRODUCTION
8.15.2. COMPUMEDICS PRODUCT PORTFOLIO
8.15.3. COMPUMEDICS RECENT ACTIVITIES
8.15.4. COMPUMEDICS SWOT
8.16. FISHER AND PAYKEL HEALTHCARE CORP. LTD
8.16.1. INTRODUCTION
8.16.2. FISHER AND PAYKEL PRODUCT PORTFOLIO
8.16.3. FISHER AND PAYKEL RECENT ACTIVITIES
8.16.4. FISHER AND PAYKEL SWOT
8.17. CHART INDUSTRIES
8.17.1. INTRODUCTION
8.17.2. CHART PRODUCT PORTFOLIO
8.17.3. CHART RECENT ACTIVITIES
8.17.4. CHART SWOT
8.18. INVACARE CORPORATION
8.18.1. INTRODUCTION
8.18.2. INVACARE PRODUCT PORTFOLIO
8.18.3. INVACARE RECENT ACTIVITIES
8.18.4. INVACARE SWOT
8.19. DRAGER MEDICAL GMBH
8.19.1. INTRODUCTION
8.19.2. DRAGER PRODUCT PORTFOLIO
8.19.3. DRAGER RECENT ACTIVITIES
8.19.4. DRAGER SWOT
8.20. HAMILTON MEDICAL AG
8.20.1. INTRODUCTION
8.20.2. HAMILTON PRODUCT PORTFOLIO
8.20.3. HAMILTON RECENT ACTIVITIES
8.20.4. HAMILTON SWOT
LIST OF TABLES
TABLE # 1 1.1. GLOBAL RESPIRATORY DISEASES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 2 GLOBAL RESPIRATORY DEVICES BY PRODUCT MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 3 GLOBAL RESPIRATORY THERAPEUTIC DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 4 GLOBAL RESPIRATORY POSITIVE AIRWAY PRESSURE DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 5 GLOBAL RESPIRATORY CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 6 GLOBAL RESPIRATORY AUTOMATIC PAP (APAP) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 7 GLOBAL RESPIRATORY BI-LEVEL PAP (BPAP) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 8 GLOBAL RESPIRATORY MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 9 GLOBAL RESPIRATORY NASAL MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 10 GLOBAL RESPIRATORY FULL-FACE MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 11 GLOBAL RESPIRATORY NASAL PILLOW MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 12 GLOBAL RESPIRATORY ORAL MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 13 GLOBAL RESPIRATORY VENTILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 14 GLOBAL RESPIRATORY ADULT VENTILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 15 GLOBAL RESPIRATORY INFANT/NEONATAL VENTILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 16 GLOBAL RESPIRATORY NEBULIZERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 17 GLOBAL RESPIRATORY HUMIDIFIERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 18 GLOBAL RESPIRATORY HEATED HUMIDIFIERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 19 GLOBAL RESPIRATORY PASSOVER HUMIDIFIERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 20 GLOBAL RESPIRATORY OXYGEN CONCENTRATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 21 GLOBAL RESPIRATORY FIXED OXYGEN CONCENTRATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 22 GLOBAL RESPIRATORY PORTABLE OXYGEN CONCENTRATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 23 GLOBAL RESPIRATORY INHALERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 24 GLOBAL RESPIRATORY DRY POWDER INHALERS (DPIS) MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 25 GLOBAL RESPIRATORY METERED DOSE INHALERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 26 GLOBAL RESPIRATORY REUSABLE RESUSCITATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 27 GLOBAL RESPIRATORY ADULT RESUSCITATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 28 GLOBAL RESPIRATORY INFANT/NEONATAL RESUSCITATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 29 GLOBAL RESPIRATORY NITRIC OXIDE DELIVERY UNITS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 30 GLOBAL RESPIRATORY OXYGEN HOODS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 31 GLOBAL RESPIRATORY DIAGNOSTIC AND MONITORING DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 32 GLOBAL RESPIRATORY PULSE OXIMETERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 33 GLOBAL RESPIRATORY PULSE OXIMETER SENSORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 34 GLOBAL RESPIRATORY PULSE OXIMETER EQUIPMENT MARKET RESEARCH AND ANALYSIS, 2014-2020 MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 35 GLOBAL RESPIRATORY CAPNOGRAPHS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 36 GLOBAL RESPIRATORY GAS ANALYZERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 37 GLOBAL RESPIRATORY SPIROMETERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 38 GLOBAL RESPIRATORY POLYSOMNOGRAPHY (PSG) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 39 GLOBAL RESPIRATORY PEAK FLOW METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 40 GLOBAL RESPIRATORY CONSUMABLES AND ACCESSORIES METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 41 GLOBAL RESPIRATORY DISPOSABLE MASKS METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 42 GLOBAL RESPIRATORY DISPOSABLE RESUSCITATORS METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 43 GLOBAL RESPIRATORY TRACHEOSTOMY TUBES METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 44 GLOBAL RESPIRATORY NASAL CANNULAS METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 45 GLOBAL RESPIRATORY OTHER CONSUMABLES AND ACCESSORIES METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 46 GLOBAL RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 47 GLOBAL RESPIRATORY DRUGS BY ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 48 GLOBAL ORAL RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 49 GLOBAL INJECTABLE RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 50 GLOBAL INHALABLE RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 51 GLOBAL RESPIRATORY DRUGS BY DRUG CLASS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 52 GLOBAL ANTICHOLINERGICS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 53 GLOBAL ANTIHISTAMINES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 54 GLOBAL BETA2 AGONISTS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 55 GLOBAL ANTIASTHMATIC COMBINATIONS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 56 GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 57 GLOBAL LEUKOTRIENE INHIBITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 58 GLOBAL MAST CELL STABILIZERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 59 GLOBAL PHOSPHODIESTERASE 4 (PDE4) INHIBITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 60 GLOBAL BRONCHODILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 61 GLOBAL DECONGESTANTS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 62 GLOBAL EXPECTORANTS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 63 GLOBAL OTHER RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 64 GLOBAL RESPIRATORY DISEASES MARKET BY END USERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 65 GLOBAL RESPIRATORY DISEASES MARKET BY HOSPITALS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 66 GLOBAL RESPIRATORY DISEASES MARKET BY HOME CARE MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 1 1.1. GLOBAL RESPIRATORY DISEASES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 2 GLOBAL RESPIRATORY DEVICES BY PRODUCT MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 3 GLOBAL RESPIRATORY THERAPEUTIC DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 4 GLOBAL RESPIRATORY POSITIVE AIRWAY PRESSURE DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 5 GLOBAL RESPIRATORY CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 6 GLOBAL RESPIRATORY AUTOMATIC PAP (APAP) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 7 GLOBAL RESPIRATORY BI-LEVEL PAP (BPAP) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 8 GLOBAL RESPIRATORY MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 9 GLOBAL RESPIRATORY NASAL MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 10 GLOBAL RESPIRATORY FULL-FACE MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 11 GLOBAL RESPIRATORY NASAL PILLOW MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 12 GLOBAL RESPIRATORY ORAL MASKS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 13 GLOBAL RESPIRATORY VENTILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 14 GLOBAL RESPIRATORY ADULT VENTILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 15 GLOBAL RESPIRATORY INFANT/NEONATAL VENTILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 16 GLOBAL RESPIRATORY NEBULIZERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 17 GLOBAL RESPIRATORY HUMIDIFIERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 18 GLOBAL RESPIRATORY HEATED HUMIDIFIERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 19 GLOBAL RESPIRATORY PASSOVER HUMIDIFIERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 20 GLOBAL RESPIRATORY OXYGEN CONCENTRATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 21 GLOBAL RESPIRATORY FIXED OXYGEN CONCENTRATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 22 GLOBAL RESPIRATORY PORTABLE OXYGEN CONCENTRATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 23 GLOBAL RESPIRATORY INHALERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 24 GLOBAL RESPIRATORY DRY POWDER INHALERS (DPIS) MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 25 GLOBAL RESPIRATORY METERED DOSE INHALERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 26 GLOBAL RESPIRATORY REUSABLE RESUSCITATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 27 GLOBAL RESPIRATORY ADULT RESUSCITATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 28 GLOBAL RESPIRATORY INFANT/NEONATAL RESUSCITATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 29 GLOBAL RESPIRATORY NITRIC OXIDE DELIVERY UNITS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 30 GLOBAL RESPIRATORY OXYGEN HOODS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 31 GLOBAL RESPIRATORY DIAGNOSTIC AND MONITORING DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 32 GLOBAL RESPIRATORY PULSE OXIMETERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 33 GLOBAL RESPIRATORY PULSE OXIMETER SENSORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 34 GLOBAL RESPIRATORY PULSE OXIMETER EQUIPMENT MARKET RESEARCH AND ANALYSIS, 2014-2020 MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 35 GLOBAL RESPIRATORY CAPNOGRAPHS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 36 GLOBAL RESPIRATORY GAS ANALYZERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 37 GLOBAL RESPIRATORY SPIROMETERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 38 GLOBAL RESPIRATORY POLYSOMNOGRAPHY (PSG) DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 39 GLOBAL RESPIRATORY PEAK FLOW METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 40 GLOBAL RESPIRATORY CONSUMABLES AND ACCESSORIES METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 41 GLOBAL RESPIRATORY DISPOSABLE MASKS METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 42 GLOBAL RESPIRATORY DISPOSABLE RESUSCITATORS METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 43 GLOBAL RESPIRATORY TRACHEOSTOMY TUBES METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 44 GLOBAL RESPIRATORY NASAL CANNULAS METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 45 GLOBAL RESPIRATORY OTHER CONSUMABLES AND ACCESSORIES METERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 46 GLOBAL RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 47 GLOBAL RESPIRATORY DRUGS BY ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 48 GLOBAL ORAL RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 49 GLOBAL INJECTABLE RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 50 GLOBAL INHALABLE RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 51 GLOBAL RESPIRATORY DRUGS BY DRUG CLASS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 52 GLOBAL ANTICHOLINERGICS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 53 GLOBAL ANTIHISTAMINES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 54 GLOBAL BETA2 AGONISTS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 55 GLOBAL ANTIASTHMATIC COMBINATIONS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 56 GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 57 GLOBAL LEUKOTRIENE INHIBITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 58 GLOBAL MAST CELL STABILIZERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 59 GLOBAL PHOSPHODIESTERASE 4 (PDE4) INHIBITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 60 GLOBAL BRONCHODILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 61 GLOBAL DECONGESTANTS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 62 GLOBAL EXPECTORANTS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 63 GLOBAL OTHER RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 64 GLOBAL RESPIRATORY DISEASES MARKET BY END USERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 65 GLOBAL RESPIRATORY DISEASES MARKET BY HOSPITALS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 66 GLOBAL RESPIRATORY DISEASES MARKET BY HOME CARE MARKET RESEARCH AND ANALYSIS, 2014-2020
LIST OF FIGURES
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANIES MENTIONED
1. PHILIPS HEALTHCARE
2. NOVARTIS
3. GLAXOSMITHKLINE
4. ASTRAZENECA
5. COVIDIEN PLC
6. ROCHE
7. BAXTER INTERNATIONAL
8. GE HEALTHCARE LIMITED
9. AIR LIQUIDE S.A.
10. OTSUKA PHARMACEUTICALS
11. PFIZER
12. MERCK AND CO.
13. BOEHRINGER INGELHEIM
14. TEVA PHARMACEUTICALS
15. COMPUMEDICS LIMITED
16. FISHER AND PAYKEL HEALTHCARE CORP. LTD
17. CHART INDUSTRIES
18. INVACARE CORPORATION
19. DRAGER MEDICAL GMBH
20. HAMILTON MEDICAL AG
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANIES MENTIONED
1. PHILIPS HEALTHCARE
2. NOVARTIS
3. GLAXOSMITHKLINE
4. ASTRAZENECA
5. COVIDIEN PLC
6. ROCHE
7. BAXTER INTERNATIONAL
8. GE HEALTHCARE LIMITED
9. AIR LIQUIDE S.A.
10. OTSUKA PHARMACEUTICALS
11. PFIZER
12. MERCK AND CO.
13. BOEHRINGER INGELHEIM
14. TEVA PHARMACEUTICALS
15. COMPUMEDICS LIMITED
16. FISHER AND PAYKEL HEALTHCARE CORP. LTD
17. CHART INDUSTRIES
18. INVACARE CORPORATION
19. DRAGER MEDICAL GMBH
20. HAMILTON MEDICAL AG
